Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Acute

Showing NaN - NaN of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • La Jolla, California
  • +8 more
Jan 31, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)

Active, not recruiting
Has Results
  • Leukemia, Myeloid, Acute
  • Oral Azacitidine
  • Placebo
  • Phoenix, Arizona
  • +247 more
Jan 13, 2023

Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • Daphne, Alabama
  • +241 more
Dec 23, 2022

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

A Long-term Follow-up Study of Patients Who Received VOR33

Recruiting
  • Leukemia, Myeloid, Acute
  • VOR33
  • La Jolla, California
  • +7 more
Aug 9, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

MDS, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid Trial in New York (CPX-351, Fludarabine, Melphalan)

Active, not recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • New York, New York
    Weill Cornell Medical College
Jan 26, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (Cytarabine, Idasanutlin, Placebo)

Terminated
Has Results
  • Leukemia, Myeloid, Acute
  • Great Neck, New York
  • +81 more
Dec 28, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (Cobimetinib, Idasanutlin, Venetoclax)

Completed
  • Leukemia, Myeloid, Acute
  • Los Angeles, California
  • +16 more
Dec 13, 2021

Leukemia, Myeloid, Acute Trial in New York (CPX-351)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • New York, New York
    Weill Cornell Medical College
Dec 10, 2021

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

Completed
Has Results
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • +5 more
  • Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
  • GVHD prophylaxis
  • Duarte, California
  • +15 more
Nov 2, 2021

Leukemia, Myeloid, Acute Trial in Spain, United States (JNJ-63709178)

Completed
  • Leukemia, Myeloid, Acute
  • Detroit, Michigan
  • +9 more
Aug 30, 2021

Patients Diagnosed With Acute Myeloid Leukemia Who Received

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • Gemtuzumab Ozogamicin
  • New York, New York
    Pfizer Investigational Site
Jul 16, 2021

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

Terminated
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Boston, Massachusetts
  • +5 more
Jun 11, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    Leukemia, Myeloid, Acute Trial in Australia, Korea, Republic of, United States (NLA101, Standard of Care (SOC) chemo)

    Terminated
    • Leukemia, Myeloid, Acute
    • NLA101
    • Standard of Care (SOC) chemotherapy
    • La Jolla, California
    • +35 more
    Mar 25, 2021

    Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)

    Completed
    Has Results
    • Leukemia, Myeloid, Acute
    • SGI-110 (guadecitabine)
    • Treatment Choice
    • Scottsdale, Arizona
    • +134 more
    Dec 21, 2020

    Leukemia, Myeloid, Acute Trial in United States (PNK-007, Cyclophosphamide, Fludarabine)

    Terminated
    • Leukemia, Myeloid, Acute
    • PNK-007
    • +3 more
    • Boston, Massachusetts
    • +6 more
    Jul 20, 2020

    Leukemia, Myeloid, Acute Trial in Worldwide (AC220)

    Completed
    Has Results
    • Leukemia, Myeloid, Acute
    • Los Angeles, California
    • +23 more
    Dec 20, 2019